Last reviewed · How we verify

ketoconazole 2% foam

Wayne Fujita, M.D. · FDA-approved active Small molecule Quality 0/100

ketoconazole 2% foam is a Small molecule drug developed by Wayne Fujita, M.D.. It is currently FDA-approved. Also known as: ketaconozole 2% foam brand name is Extina Foam., Extina, Extina Foam.

Ketoconazole 2% foam, marketed by Wayne Fujita, M.D., is a topical antifungal agent with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence and the protection afforded by its patent. The primary risk is the potential increase in competition following the patent expiry in 2028.

At a glance

Generic nameketoconazole 2% foam
Also known asketaconozole 2% foam brand name is Extina Foam., Extina, Extina Foam
SponsorWayne Fujita, M.D.
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ketoconazole 2% foam

What is ketoconazole 2% foam?

ketoconazole 2% foam is a Small molecule drug developed by Wayne Fujita, M.D..

Who makes ketoconazole 2% foam?

ketoconazole 2% foam is developed and marketed by Wayne Fujita, M.D. (see full Wayne Fujita, M.D. pipeline at /company/wayne-fujita-m-d).

Is ketoconazole 2% foam also known as anything else?

ketoconazole 2% foam is also known as ketaconozole 2% foam brand name is Extina Foam., Extina, Extina Foam.

What development phase is ketoconazole 2% foam in?

ketoconazole 2% foam is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing